Elena Viboch is a Managing Director at General Catalyst, where she invests in Seed through Series C stage startups across Healthcare, Life Sciences, and Health Technology. She invests in companies across the United States, North America, and Europe, and has invested in companies like Odyssey Therapeutics, Dewpoint Therapeutics, Eikon, Variant Bio, and Alpha-9 Oncology. She previously served as a Partner at General Catalyst and earlier held roles including Investment Director at SoftBank Investment Advisers; Director of Corporate Development at NanoString Technologies; Director of Business Development & Operations at Carmot Therapeutics; Senior Manager, Corporate Development & Strategy at FLX Bio; Corporate Development at Jazz Pharmaceuticals; Investor at Kearny Venture Partners; and Consultant at Putnam Associates. Elena is based in San Francisco, California, and attended Harvard Business School.
Elena Viboch, Managing Director @ General Catalyst. Profile with intro opportunities and ranking information.